7/1/2003

Johnson & Johnson has reached a deal with Millennium Pharmaceuticals, offering the Cambridge, Mass.-based company up to $750 million to market its cancer drug Velcade overseas. Analysts say Johnson & Johnson is trying to build its cancer drug business.

Related Summaries